CN115636879A - 一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 - Google Patents
一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 Download PDFInfo
- Publication number
- CN115636879A CN115636879A CN202211217124.6A CN202211217124A CN115636879A CN 115636879 A CN115636879 A CN 115636879A CN 202211217124 A CN202211217124 A CN 202211217124A CN 115636879 A CN115636879 A CN 115636879A
- Authority
- CN
- China
- Prior art keywords
- nanobody
- antibody
- proteomics
- generation sequencing
- nano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000007481 next generation sequencing Methods 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 23
- 230000016784 immunoglobulin production Effects 0.000 title description 2
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 238000001514 detection method Methods 0.000 claims abstract description 11
- 238000001819 mass spectrum Methods 0.000 claims abstract description 10
- 238000001976 enzyme digestion Methods 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 46
- 102000004169 proteins and genes Human genes 0.000 claims description 44
- 102000036639 antigens Human genes 0.000 claims description 20
- 108091007433 antigens Proteins 0.000 claims description 20
- 239000000427 antigen Substances 0.000 claims description 19
- 230000003053 immunization Effects 0.000 claims description 11
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 10
- 239000002299 complementary DNA Substances 0.000 claims description 10
- 108020004999 messenger RNA Proteins 0.000 claims description 10
- 241000282836 Camelus dromedarius Species 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 238000002649 immunization Methods 0.000 claims description 8
- 238000001261 affinity purification Methods 0.000 claims description 7
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 230000027455 binding Effects 0.000 claims description 3
- 238000004949 mass spectrometry Methods 0.000 claims description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 abstract description 17
- 238000012795 verification Methods 0.000 abstract description 5
- 230000004907 flux Effects 0.000 abstract description 3
- 235000018102 proteins Nutrition 0.000 description 37
- 239000000523 sample Substances 0.000 description 19
- 108010033276 Peptide Fragments Proteins 0.000 description 12
- 102000007079 Peptide Fragments Human genes 0.000 description 12
- 238000002965 ELISA Methods 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 102100031780 Endonuclease Human genes 0.000 description 6
- 108010042407 Endonucleases Proteins 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000002823 phage display Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 239000004472 Lysine Substances 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 238000006062 fragmentation reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 241000282832 Camelidae Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 101710120037 Toxin CcdB Proteins 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001583 randomness test Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZBQCCTCQUCOXBO-UHFFFAOYSA-N 4-(4-aminophenyl)-2,2,6,6-tetramethylcyclohex-3-en-1-amine Chemical compound CC1(C)C(N)C(C)(C)CC(C=2C=CC(N)=CC=2)=C1 ZBQCCTCQUCOXBO-UHFFFAOYSA-N 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- 101100454808 Caenorhabditis elegans lgg-2 gene Proteins 0.000 description 1
- 101100217502 Caenorhabditis elegans lgg-3 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- -1 NSI ion Chemical class 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241001535172 Severe fever with thrombocytopenia virus Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 238000013357 binding ELISA Methods 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012997 ficoll-paque Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000012562 protein A resin Substances 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211217124.6A CN115636879B (zh) | 2022-09-30 | 2022-09-30 | 一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211217124.6A CN115636879B (zh) | 2022-09-30 | 2022-09-30 | 一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115636879A true CN115636879A (zh) | 2023-01-24 |
CN115636879B CN115636879B (zh) | 2024-01-05 |
Family
ID=84941946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211217124.6A Active CN115636879B (zh) | 2022-09-30 | 2022-09-30 | 一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115636879B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110312505A1 (en) * | 2010-05-17 | 2011-12-22 | Sai Reddy | Rapid Isolation of Monoclonal Antibodies from Animals |
US20130178370A1 (en) * | 2011-11-23 | 2013-07-11 | The Board Of Regents Of The University Of Texas System | Proteomic identification of antibodies |
CN106661629A (zh) * | 2014-08-07 | 2017-05-10 | 深圳华大基因科技有限公司 | 筛选纳米抗体的方法及系统 |
CN109425662A (zh) * | 2017-08-23 | 2019-03-05 | 深圳华大基因研究院 | 一种鉴定蛋白的方法及系统 |
CN115044983A (zh) * | 2022-06-23 | 2022-09-13 | 杭州中晟纳博生物科技有限公司 | 一种抗原特异性纳米抗体多肽文库的制备方法及应用 |
CN116814520A (zh) * | 2023-06-01 | 2023-09-29 | 宁波大学 | 一种利用亚精胺提高等鞭金藻中岩藻黄素含量的方法 |
-
2022
- 2022-09-30 CN CN202211217124.6A patent/CN115636879B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110312505A1 (en) * | 2010-05-17 | 2011-12-22 | Sai Reddy | Rapid Isolation of Monoclonal Antibodies from Animals |
US20130178370A1 (en) * | 2011-11-23 | 2013-07-11 | The Board Of Regents Of The University Of Texas System | Proteomic identification of antibodies |
CN106661629A (zh) * | 2014-08-07 | 2017-05-10 | 深圳华大基因科技有限公司 | 筛选纳米抗体的方法及系统 |
US20170226566A1 (en) * | 2014-08-07 | 2017-08-10 | Bgi Shenzhen Co., Limited | Method and system for screening nanobody |
CN109425662A (zh) * | 2017-08-23 | 2019-03-05 | 深圳华大基因研究院 | 一种鉴定蛋白的方法及系统 |
CN115044983A (zh) * | 2022-06-23 | 2022-09-13 | 杭州中晟纳博生物科技有限公司 | 一种抗原特异性纳米抗体多肽文库的制备方法及应用 |
CN116814520A (zh) * | 2023-06-01 | 2023-09-29 | 宁波大学 | 一种利用亚精胺提高等鞭金藻中岩藻黄素含量的方法 |
Non-Patent Citations (3)
Title |
---|
BINGHAO WANG等: "Development of functional anti-Gn nanobodies specific for SFTSV based on next-generation sequencing and proteomics", 《PROTEIN SCIENCE》, vol. 31, no. 11 * |
PETER C FRIDY等: "A robust pipeline for rapid production of versatile nanobody repertoires", 《NATURE METHODS》, vol. 11, pages 1253, XP055399861, DOI: 10.1038/nmeth.3170 * |
张文杰: "来源于条纹斑竹鲨抗HBsAg单域抗体的筛选及重组抗体的活性研究", 《中国知网》 * |
Also Published As
Publication number | Publication date |
---|---|
CN115636879B (zh) | 2024-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10175249B2 (en) | Proteomic identification of antibodies | |
US11866785B2 (en) | Tumor specific antibodies and T-cell receptors and methods of identifying the same | |
US11447891B2 (en) | Compositions and methods for rapid production of versatile nanobody repertoires | |
CN102333790A (zh) | 检测维生素d的分析方法及用于其的抗体 | |
JP2022528807A (ja) | 宿主細胞タンパク質の同定 | |
US20210302433A1 (en) | Methods for characterizing low-abundance host cell proteins | |
CN107383199B (zh) | 一种s-腺苷蛋氨酸合成酶的单克隆抗体及其应用 | |
JP6781854B1 (ja) | モノクローナル抗体の酵母による製造方法およびスクリーニング方法 | |
CN115636879B (zh) | 一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 | |
CN117859065A (zh) | 通过位置选择性二甲基化进行蛋白质n-末端从头测序 | |
US10954550B2 (en) | Method and system for screening nanobody | |
CN109748966B (zh) | 一种抗His标签的重链抗体及其应用 | |
WO2022120128A1 (en) | Compositions and methods for rapid production of versatile single domain antibody repertoires | |
JP6152908B2 (ja) | ペプチド断片の調製方法および分析方法 | |
Le Bihan et al. | de Novo Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination | |
WO2021014660A1 (ja) | モノクローナル抗体の酵母による製造方法およびスクリーニング方法 | |
Georgiou et al. | Proteomic identification of antibodies | |
JP2021016395A (ja) | モノクローナル抗体の酵母による製造方法およびスクリーニング方法 | |
JP2013017423A (ja) | 抗ヒスチジンタグ抗体 | |
Pattison | Characterisation of next generation affinity reagents | |
CN117820432A (zh) | 两条与金黄色葡萄球菌特异性结合的多肽筛选及其应用 | |
CN117836308A (zh) | 用于选择特异性结合剂的手段和方法 | |
CN117209600A (zh) | Ss-b结合蛋白、制备方法和应用 | |
JP2023107630A (ja) | 抗体を製造するための方法及び抗体を評価するための方法並びにこれらに関連するキット | |
JP2012157353A (ja) | 抗トリガーファクターモノクローナル抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230330 Address after: Room 522, Building F6, Jiangsu Life Science and Technology Innovation Park, No. 9 Weidi Road, Xianlin Street, Qixia District, Nanjing City, Jiangsu Province, 210046 Applicant after: Nanjing Jisi Huiyuan Biotechnology Co.,Ltd. Applicant after: Nanjing Jitai Biotechnology Co.,Ltd. Address before: Building F6, Jiangsu Life Science and Technology Innovation Park, No. 9, Weidi Road, Xianlin Street, Qixia District, Nanjing, Jiangsu, 210046 Applicant before: Nanjing Jisi Huiyuan Biotechnology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |